Haematologica (May 2023)

B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphoma

  • Lorenz Thurner,
  • Natalie Fadle,
  • Evi Regitz,
  • Sophie Roth,
  • Onur Cetin,
  • Igor Age Kos,
  • Simon Mauro Hess,
  • Julia Bein,
  • Rainer Maria Bohle,
  • Martine Vornanen,
  • Christer Sundström,
  • Laurence de Leval,
  • Enrico Tiacci,
  • Peter Borchmann,
  • Andreas Engert,
  • Viola Poeschel,
  • Gerhard Held,
  • Eva C. Schwarz,
  • Frank Neumann,
  • Klaus-Dieter Preuss,
  • Markus Hoth,
  • Ralf Küppers,
  • Karola Lehman,
  • Martin-Leo Hansmann,
  • Sören L. Becker,
  • Moritz Bewarder,
  • Sylvia Hartmann

DOI
https://doi.org/10.3324/haematol.2023.282698
Journal volume & issue
Vol. 108, no. 12

Abstract

Read online

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and its superantigen MID/hag, associated with extralong CDR3 and HLA-DRB1*04 or HLADRB1* 07 haplotype. The aim of the present study was to extend the antigen screening to further bacteria and viruses. The fragment antibody-binding (Fab) regions of seven new and 15 previously reported cases were analyzed. The reactivity of non-Moraxella spp.-reactive Fab regions against lysates of Rothia mucilaginosa was observed in 5/22 (22.7%) cases. Galactofuranosyl transferase (Gltf) and 2,3-butanediol dehydrogenase (Bdh) of R. mucilaginosa were identified by comparative silver- and immuno-staining in two-dimensional gels, with subsequent mass spectrometry and validation by western blots and enzyme-linked immunosorbent assay. Both R. mucilaginosa Gltf and Bdh induced BCR pathway activation and proliferation in vitro. Apoptosis was induced by recombinant Gltf/ETA’-immunotoxin conjugates in DEV cells expressing recombinant R. mucilaginosa-reactive BCR. Reactivity against M. catarrhalis RpoC was confirmed in 3/7 newly expressed BCR (total 10/22 reactive to Moraxella spp.), resulting in 15/22 (68.2%) cases with BCR reactivity against defined bacterial antigens. These findings strengthen the hypothesis of bacterial trigger contributing to subsets of NLPHL.